Primer: Brii Biosciences (2137 HK) - Aug 2026
Brii Biosciences is a clinical-stage biotechnology company with a strategic focus on developing a functional cure for Hepatitis B (HBV), a...
93 Views
𝛼SK or SearchENTITY
Brii Biosciences (2137 HK)
Brii Biosciences (2137 HK)
36
Analysis
Health Care • China
Brii Biosciences is a biotechnology company focused on developing therapies for infectious and central nervous system diseases. The company has a broad pipeline of therapeutic candidates, with lead programs targeting hepatitis B virus (HBV) infection, and also develops treatments for multi-drug resistant bacterial infections. Brii Biosciences is headquartered in Beijing, China, and was founded in 2017.
morex